https://youtu.be/watch?v=_DOF6qPzmWY

Following the outbreak of COVD-19, on Wednesday 15th April, Cure Leukaemia and Geoff Thomas reluctantly announced the cancellation of GT15, with a view to completing the challenge in 2021.

Geoff Thomas and his team of amateur cyclists will ride the full Tour de France, one day ahead of the professionals in 2021 to raise over £1m for Cure Leukaemia.

1 July – 24 July 2021

21

Amateur Cyclists

21

Stages

3460

Kilometres
MEET THE GT15 TEAMMAKE A DONATION TO THE GT15 TEAMSPONSORSHIP OPPORTUNITIES

Register your interest in riding the Tour de France for Cure Leukaemia in 2021
Thursday July 1st to July 24th

Geoff Thomas Day

On July 4th 2020, Geoff and his team would have been cycling stage 9 of the Tour de France, one day ahead of the professionals. This day marks 17 years since the former Crystal Palace captain was diagnosed with chronic myeloid leukaemia.

To mark this key date, Saturday July 4th will be Geoff Thomas Day, and despite not being able to ride the Tour de France route this Summer, he is urging the football community & UK public to take on their own challenges to raise funds towards his team’s £1m target.

“Geoff Thomas Day’ is a great idea and I would urge football fans and the wider public to get involved to help Geoff and his team raise £1m for Cure Leukaemia this summer.”

Gary Lineker – BBC Match of the Day presenter

GET INVOLVED IN GEOFF THOMAS DAYCREATE YOUR GT DAY FUNDRAISING PAGE

The GT15 Team's £1,000,000 target

Geoff will carefully select the team of amateur cyclists who will join him for their GT15 Tour de France, one day ahead challenge from Thursday 1st July to Saturday 24th July 2021.

Each rider has committed to raising a minimum of £30,000 for Cure Leukaemia towards the team’s combined target of £1,000,000. The funds raised by GT15 will be invested in the national Trials Acceleration Programme Network (TAP) network.

Cure Leukaemia fund specialist research nurses at the 12 blood cancer centres across the UK that comprise the TAP network. These nurses allow clinical trials of pioneering and potentially life-saving treatments for blood cancer to run, giving patients from a catchment area of over 20 million people access to these new drugs. Many of these nurses have been re-deployed to directly help fight COVID-19 on the front-line.

The TAP network, which is co-ordinated and run from its Hub in the Centre for Clinical Haematology at Birmingham’s Queen Elizabeth Hospital, allows rapid and accelerated assessment of these new treatments for blood cancer. Every penny raised by Geoff and the team will be invested in this network and will not only directly help save lives but will also help hasten global progress towards eradicating all forms of blood cancer.